Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

CAPLIN POINT LABORATORIES LTD.

NSE : CAPLIPOINTBSE : 524742ISIN CODE : INE475E01026Industry : Pharmaceuticals & DrugsHouse : Private

BSE1314.80-23.7 (-1.77 %)

PREV CLOSE ( ) 1338.50

OPEN PRICE ( ) 1349.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 3187

TODAY'S LOW / HIGH ( )1300.65 1349.00

52 WK LOW / HIGH ( )690.4 1617.8

NSE1314.95-26.35 (-1.96 %)

PREV CLOSE( ) 1341.30

OPEN PRICE ( ) 1340.05

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1314.95 (2)

VOLUME 25278

TODAY'S LOW / HIGH( ) 1297.65 1341.00

52 WK LOW / HIGH ( )691.1 1619.05

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1990

Management Info

C C Paarthipan - Chairman Sridhar Ganesan - Managing Director

Registered Office

Address 3rd Floor, “ Ashvich Towers”,No.3, Developed Plots Industrial Estate,Perungudi,
Chennai,
Tamil Nadu-600096

Phone 044-24968000 / 8012772888 / 71148000

Email info@caplinpoint.net

Website www.caplinpoint.net

Registrars Details

Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)

II Floor , Kences Towers,No 1 Ramakrishna Street,North Usman Road, T Nagar,Chennai

Listing : BSE, NSE, Chennai

NEWS

06May Caplin Point gets Colombia's INVIMA ap
Caplin Point Laboratories has received Colombia's INVIMA approval for it..

06May Caplin Point moves up on getting Colom
Caplin Point Laboratories is currently trading at Rs. 1301.70, up by 2.9..

16Apr Caplin Point Laboratories’ arm gets fi
Caplin Point Laboratories’ subsidiary company -- Caplin Steriles (Caplin..

16Apr Caplin Point Laboratories informs abou
Caplin Point Laboratories has informed that it enclosed press release re..

28Mar Caplin Point Laboratories’ arm gets US
Caplin Point Laboratories’ subsidiary -- Caplin Steriles has been grante..

Financials

Rs. in Millions

	QTR Mar 24	ANNUAL 24
Net Profit	698.8	2837.1
Gross Profit	869.1	3657.4
Operating Profit	938.6	3929.2
Net Sales	1393.8	6250.9

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE) 26643.70 (0.58%)	M.Cap ( in Cr)56616.00
Pfizer (BSE) 4473.85 (1.59%)	M.Cap ( in Cr)20466.85
Glaxosmithkline Phar (BSE) 2355.75 (2.80%)	M.Cap ( in Cr)39907.83
Concord Biotech (BSE) 1494.85 (4.43%)	M.Cap ( in Cr)15638.55
Zydus Lifesciences (BSE) 1104.45 (5.00%)	M.Cap ( in Cr)111133.51

Shareholding Pattern

	PROMOTERS	70.62%
	NON-INSTITUTION	24.95%
	MUTUAL FUNDS/UTI	1.06%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
UTI Healthcare Fund...	1.39
UTI Large & Mid Cap...	0.49
UTI Aggressive Hybr...	0.48
Motilal Oswal S&P B...	0.29
UTI Retirement Fund	0.25
Groww Nifty Total M...	0.02
HDFC S&P BSE 500 ETF	0.02

Risk Disclosures on Derivatives

Smart Quotes

CAPLIN POINT LABORATORIES LTD.